JP2011500594A5 - - Google Patents

Download PDF

Info

Publication number
JP2011500594A5
JP2011500594A5 JP2010529081A JP2010529081A JP2011500594A5 JP 2011500594 A5 JP2011500594 A5 JP 2011500594A5 JP 2010529081 A JP2010529081 A JP 2010529081A JP 2010529081 A JP2010529081 A JP 2010529081A JP 2011500594 A5 JP2011500594 A5 JP 2011500594A5
Authority
JP
Japan
Prior art keywords
methyl
phenyl
amino
triazin
methylamino
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2010529081A
Other languages
English (en)
Japanese (ja)
Other versions
JP2011500594A (ja
JP5372943B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2008/079517 external-priority patent/WO2009049157A1/en
Publication of JP2011500594A publication Critical patent/JP2011500594A/ja
Publication of JP2011500594A5 publication Critical patent/JP2011500594A5/ja
Application granted granted Critical
Publication of JP5372943B2 publication Critical patent/JP5372943B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2010529081A 2007-10-11 2008-10-10 新規ｓＥＨ阻害剤およびそれらの使用 Expired - Fee Related JP5372943B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US97915407P 2007-10-11 2007-10-11
US60/979,154 2007-10-11
PCT/US2008/079517 WO2009049157A1 (en) 2007-10-11 2008-10-10 Novel seh inhibitors and their use

Publications (3)

Publication Number Publication Date
JP2011500594A JP2011500594A (ja) 2011-01-06
JP2011500594A5 true JP2011500594A5 (enExample) 2011-11-24
JP5372943B2 JP5372943B2 (ja) 2013-12-18

Family

ID=40549589

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010529081A Expired - Fee Related JP5372943B2 (ja) 2007-10-11 2008-10-10 新規ｓＥＨ阻害剤およびそれらの使用

Country Status (28)

Country Link
US (2) US8173805B2 (enExample)
EP (1) EP2214487B1 (enExample)
JP (1) JP5372943B2 (enExample)
KR (1) KR101546111B1 (enExample)
CN (1) CN101896065B (enExample)
AU (1) AU2008310732B2 (enExample)
BR (1) BRPI0817542A2 (enExample)
CA (1) CA2702265C (enExample)
CO (1) CO6270285A2 (enExample)
CR (1) CR11423A (enExample)
CY (1) CY1114865T1 (enExample)
DK (1) DK2214487T3 (enExample)
DO (1) DOP2010000101A (enExample)
EA (1) EA018414B1 (enExample)
ES (1) ES2445444T3 (enExample)
HR (1) HRP20140105T1 (enExample)
IL (1) IL204889A (enExample)
MA (1) MA31761B1 (enExample)
MX (1) MX2010003942A (enExample)
MY (1) MY157116A (enExample)
NZ (1) NZ584471A (enExample)
PL (1) PL2214487T3 (enExample)
PT (1) PT2214487E (enExample)
RS (1) RS53180B (enExample)
SI (1) SI2214487T1 (enExample)
UA (1) UA107444C2 (enExample)
WO (1) WO2009049157A1 (enExample)
ZA (1) ZA201002465B (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008105968A1 (en) 2006-11-03 2008-09-04 Smithkline Beecham Corporation Novel seh inhibitors and their use
JP5411867B2 (ja) 2007-10-11 2014-02-12 グラクソスミスクライン・リミテッド・ライアビリティ・カンパニー 新規ｓＥＨ阻害剤およびそれらの使用
MY157116A (en) 2007-10-11 2016-05-13 Glaxosmithkline Llc Novel seh inhibitors and their use
FR2948027A1 (fr) 2009-07-17 2011-01-21 Merck Sante Sas Derives amines de dihydro-1,3,5-triazine pour leur utilisation dans le traitement des maladies associees a une ischemie et/ou une reperfusion
EP2567959B1 (en) 2011-09-12 2014-04-16 Sanofi 6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
US8809552B2 (en) * 2011-11-01 2014-08-19 Hoffmann-La Roche Inc. Azetidine compounds, compositions and methods of use
WO2015003360A2 (en) 2013-07-11 2015-01-15 Agios Pharmaceuticals, Inc. Therapeutically active compounds and their methods of use
WO2015104422A1 (en) 2014-01-13 2015-07-16 Basf Se Dihydrothiophene compounds for controlling invertebrate pests
WO2015155129A1 (en) * 2014-04-07 2015-10-15 Basf Se Diaminotriazine compound
WO2016058544A1 (en) 2014-10-16 2016-04-21 Syros Pharmaceuticals, Inc. Inhibitors of cyclin-dependent kinase 7 (cdk7)
US20210378995A1 (en) * 2018-10-10 2021-12-09 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods and topical pharmaceutical compositions for the treatment of skin microvascular dysfunction
CN120583949A (zh) 2022-11-18 2025-09-02 巴塞罗那大学 sigma-1受体双重抑制剂和可溶性环氧化物水解酶及其在疼痛治疗中的用途
WO2024105225A1 (en) 2022-11-18 2024-05-23 Universitat De Barcelona Synergistic combinations of a sigma receptor 1 (s1r) antagonist and a soluble epoxide hydrolase inhibitor (sehi) and their use in the treatment of pain
WO2026058000A2 (en) 2024-09-13 2026-03-19 Ucl Business Ltd Methods

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5420283A (en) * 1993-08-02 1995-05-30 Pfizer Inc. Resolution of (R)-2-benzylsuccinic acid 4-[4-(N-t-butoxycarbonylmethylamino)-piperidine] amide
WO2000038683A1 (en) * 1998-12-23 2000-07-06 Du Pont Pharmaceuticals Company THROMBIN OR FACTOR Xa INHIBITORS
US6630490B2 (en) * 2000-07-07 2003-10-07 Neotherapeutics, Inc. Methods for treatment of disease-induced peripheral neuropathy and related conditions
US6451814B1 (en) * 2000-07-17 2002-09-17 Wyeth Heterocyclic β-3 adrenergic receptor agonists
KR100600550B1 (ko) 2000-10-20 2006-07-13 에자이 가부시키가이샤 질소 함유 방향환 유도체
WO2002058736A2 (en) * 2000-12-12 2002-08-01 Neotherapetics, Inc. Use of 9-substituted purine analogues and other molecules to stimulate neurogenesis
BR0116493A (pt) * 2000-12-21 2003-09-30 Vertex Pharma Compostos de pirazol úteis como inibidores de proteìna cinase
WO2003002555A1 (en) * 2001-06-29 2003-01-09 Boehringer Ingelheim Pharmaceuticals Inc. Methods of using soluble epoxide hydrolase inhibitors
US20030055249A1 (en) 2001-07-17 2003-03-20 Fick David B. Synthesis and methods of use of pyrimidine analogues and derivatives
TWI329105B (en) * 2002-02-01 2010-08-21 Rigel Pharmaceuticals Inc 2,4-pyrimidinediamine compounds and their uses
ATE511858T1 (de) * 2002-02-05 2011-06-15 Astellas Pharma Inc 2,4,6-triamino-1,3,5-triazin-derivat
AU2003232148A1 (en) 2002-05-16 2003-12-02 Pharmacia Corporation A selective inos inhibitor and a pde inhibitor in combination for the treatment of respiratory diseases
US20050197350A1 (en) * 2003-03-31 2005-09-08 Taisho Pharmaceutical Co., Ltd. Novel quinoline, tetrahydroquinazoline, and pyrimidine derivatives and methods of treatment related to the use thereof
CA2531061A1 (en) * 2003-07-02 2005-01-13 Vertex Pharmaceuticals Incorporated Pyrimidines useful as modulators of voltage-gated ion channels
US7223759B2 (en) * 2003-09-15 2007-05-29 Anadys Pharmaceuticals, Inc. Antibacterial 3,5-diaminopiperidine-substituted aromatic and heteroaromatic compounds
WO2005028438A1 (ja) * 2003-09-22 2005-03-31 Banyu Pharmaceutical Co., Ltd. 新規ピペリジン誘導体
GB0401269D0 (en) 2004-01-21 2004-02-25 Astrazeneca Ab Compounds
US20060069110A1 (en) * 2004-09-27 2006-03-30 Andersen Denise L Substituted heterocyclic compounds and methods of use
WO2006053109A1 (en) 2004-11-10 2006-05-18 Synta Pharmaceuticals Corp. Heteroaryl compounds
WO2006065820A2 (en) 2004-12-14 2006-06-22 Vertex Pharmaceuticals Incorporated Pyrimidine inhibitors of erk protein kinase and uses therof
US20060276515A1 (en) * 2005-05-06 2006-12-07 Cywin Charles L Soluble Epoxide Hydrolase Inhibitors and Methods of Using Same
WO2007044491A1 (en) * 2005-10-07 2007-04-19 Boehringer Ingelheim International Gmbh N-substituted pyridinone or pyrimidinone compounds useful as soluble epoxide hydrolase inhibitors
WO2007098352A2 (en) * 2006-02-16 2007-08-30 Boehringer Ingelheim International Gmbh Substituted pyridineamide compounds useful as soluble epoxide hydrolase inhibitors
AR059826A1 (es) * 2006-03-13 2008-04-30 Univ California Inhibidores de urea conformacionalmente restringidos de epoxido hidrolasa soluble
WO2008105968A1 (en) * 2006-11-03 2008-09-04 Smithkline Beecham Corporation Novel seh inhibitors and their use
JP5411867B2 (ja) * 2007-10-11 2014-02-12 グラクソスミスクライン・リミテッド・ライアビリティ・カンパニー 新規ｓＥＨ阻害剤およびそれらの使用
MY157116A (en) * 2007-10-11 2016-05-13 Glaxosmithkline Llc Novel seh inhibitors and their use
EP2217068A4 (en) * 2007-10-11 2011-09-14 Glaxosmithkline Llc NOVEL INHIBITORS OF SEH AND THEIR USE
JPWO2009048154A1 (ja) 2007-10-12 2011-02-24 日本電気株式会社 半導体装置及びその設計方法
WO2009070497A1 (en) 2007-11-28 2009-06-04 Smithkline Beecham Corporation SEH AND 11 β-HSD1 INHIBITORS AND THEIR USE
WO2009073772A1 (en) 2007-12-06 2009-06-11 Smithkline Beecham Corporation Novel seh inhibitors and their use
WO2009097475A1 (en) 2008-01-30 2009-08-06 Smithkline Beecham Corporation NOVEL sEH INHIBITORS AND THEIR USE
EP2240021A4 (en) * 2008-01-30 2011-08-17 Glaxosmithkline Llc NEW SEH-HEMMER AND ITS USE
JP2011510998A (ja) * 2008-01-30 2011-04-07 グラクソスミスクライン・リミテッド・ライアビリティ・カンパニー 新規ｓＥＨ阻害剤およびその使用
WO2010011917A1 (en) 2008-07-25 2010-01-28 Glaxosmithkline Llc SEH AND 11β-HSD1 DUAL INHIBITORS

Similar Documents

Publication Publication Date Title
HRP20140105T1 (hr) Novi inhibitori seh i njihova upotreba
JP2013505903A5 (enExample)
JP2011500596A5 (enExample)
JP2016526561A5 (enExample)
JP2018522823A5 (enExample)
RU2401265C2 (ru) Соединения и композиции в качестве ингибиторов протеинкиназы
RU2423354C2 (ru) Соединения и композиции - модуляторы сигнального пути hedgehog
RU2015113746A (ru) Замещенные сульфонамиды
RU2017145650A (ru) Ингибиторы тирозинкиназы брутона
ME00427B (me) N-supstituisani hidroksipiramidinon karboksamidni inhibitori hiv integraze
JP2017530199A5 (enExample)
JP2016506369A5 (enExample)
CA2663366A1 (en) Compounds and compositions as protein kinase inhibitors
ME01903B (me) Hetrociklički sulfonamidi, njihova upotreba i farmaceutski pripravci
NZ600084A (en) Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
JP2013510876A5 (enExample)
HRP20180844T1 (hr) Terapeutski aktvni spojevi i postupci njihovog korištenja
HRP20210143T1 (hr) 2-heteroaril-3-okso-2,3-dihidropiridazin-4-karboksamidi za liječenje raka
RU2008135690A (ru) Соединения и композиции в качестве ингибиторов протеинкиназы
CA2601508A1 (en) Cyclopropanecarboxamide derivatives
IL269241B (en) Somatostatin modulators and uses thereof
JP2013530240A5 (enExample)
CA2582029A1 (en) Aryl nitrogen-containing bicyclic compounds and methods of use
AR089134A1 (es) Arilos y heteroarilos biciclicos inhibidores de los canales de sodio
RU2017121958A (ru) Замещенные диаминокарбоксамидные и диаминокарбонитрильные производные пиримидинов, их композиции и способы лечения с их помощью